Bulletin of Experimental Biology and Medicine

, Volume 164, Issue 3, pp 339–343 | Cite as

Activation of NK Cells in Mixed Cultures of Wharton’s Jelly Mesenchymal Stromal Cells and Peripheral Blood Lymphocytes

  • E. V. Svirshchevskaya
  • A. M. Poltavtsev
  • G. Zh. Os’mak
  • R. A. Poltavtseva
Article

Mesenchymal stromal cells possess immunosuppressive properties that might be used for the therapy of inflammatory diseases of various geneses. The effects of mesenchymal stromal cells depend on their lifetime in the recipient tissues. During heterologous transplantation, mesenchymal stromal cells are eliminated by NK cells. We studied NK cell formation in mixed cultures of Wharton’s jelly mesenchymal stromal cells and peripheral blood lymphocytes from an autologous donor. Lymphocytes were activated by a mitogen or IL-2. The lifetime of mesenchymal stromal cells was estimated by MTT test. Cytotoxic activity and phenotype of NK cells were evaluated by flow cytometry. It was found that activation of NK cells depended on IL-2 and was registered on day 2 of incubation with IL-2. In cultures with mitogen-activated lymphocytes, cytotoxicity was observed after 5-6 days. Cytotoxicity of NK correlated with significant decrease in CD16+ and increase in CD56+ NK and with reduction of mesenchymal stromal cell viability. Thus, the main mechanism of elimination of mesenchymal stromal cells is cytotoxicity of NK cells that depended on IL-2 production.

Key Words

mesenchymal stromal cells lymphocyte activation natural killers 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lupatov AY, Kim YS, Bystrykh OA, Vakhrushev IV, Pavlovich SV, Yarygin KN, Sukhikh GT. Effect of Fibroblast-Like Cells of Mesenchymal Origin of Cytotoxic Activity of Lymphocytes against NK-Sensitive Target Cells. Bull. Exp. Biol. Med. 2017;162(4):552-557.CrossRefPubMedGoogle Scholar
  2. 2.
    Svirshchevskaya EV, Poltavtseva RA, Beletskii IP, Selezneva II, Sukhikh GT. Antiproliferative Effects of Mesenchymal Stem Cells and Epithelial Cells on Lymphocytes. Bull. Exp. Biol. Med. 2016;161(4):518-522.CrossRefPubMedGoogle Scholar
  3. 3.
    DelaRosa O, Sánchez-Correa B, Morgado S, Ramírez C, del Río B, Menta R, Lombardo E, Tarazona R, Casado JG. Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysis. Stem Cells Dev. 2012;21(8):1333-1343.CrossRefPubMedGoogle Scholar
  4. 4.
    Dressel R, Nolte J, Elsner L, Novota P, Guan K, Streckfuss-Bömeke K, Hasenfuss G, Jaenisch R, Engel W. Pluripotent stem cells are highly susceptible targets for syngeneic, allogeneic, and xenogeneic natural killer cells. FASEB J. 2010;24(7):2164-2177.CrossRefPubMedGoogle Scholar
  5. 5.
    Jacobs SA, Plessers J, Pinxteren J, Roobrouck VD, Verfaillie CM, Van Gool SW. Mutual interaction between human multipotent adult progenitor cells and NK cells. Cell Transplant. 2014;23(9):1099-1110.CrossRefPubMedGoogle Scholar
  6. 6.
    Li Y, Qu YH, Wu YF, Liu L, Lin XH, Huang K, Wei J. Bone marrow mesenchymal stem cells suppressing activation of allogeneic cytokine-induced killer/natural killer cells either by direct or indirect interaction. Cell Biol. Int. 2015;39(4):435-445.CrossRefPubMedGoogle Scholar
  7. 7.
    Lugli E, Hudspeth K, Roberto A, Mavilio D. Tissue-resident and memory properties of human T-cell and NK-cell subsets. Eur. J. Immunol. 2016;46(8):1809-1817.CrossRefPubMedGoogle Scholar
  8. 8.
    Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, Marcenaro E, O’Shea M.A, Kinter A, Kovacs C, Moretta A, Fauci AS. Characterization of CD56/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc. Natl Acad. Sci. USA. 2005;102(8):2886-2891.Google Scholar
  9. 9.
    Tseng HC, Arasteh A, Paranjpe A, Teruel A, Yang W, Behel A, Alva JA, Walter G, Head C, Ishikawa TO, Herschman HR, Cacalano N, Pyle AD, Park NH, Jewett A. Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or reprogramming activates NK cells. PLoS One. 2010;5(7):e11590. doi:  https://doi.org/10.1371/journal.pone.0011590.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Wang W, Erbe AK, Alderson KA, Phillips E, Gallenberger M, Gan J, Campana D, Hank JA, Sondel PM. Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion. Cancer Immunol. Immunother. 2016;65(9):1047-1059.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • E. V. Svirshchevskaya
    • 1
  • A. M. Poltavtsev
    • 2
  • G. Zh. Os’mak
    • 3
  • R. A. Poltavtseva
    • 3
  1. 1.M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of SciencesMoscowRussia
  2. 2.Institute of Applied MechanicsRussian Academy of SciencesMoscowRussia
  3. 3.V. I. Kulakov Research Center of Obstetrics, Gynecology, and PerinatologyMinistry of the Health of the Russian FederationMoscowRussia

Personalised recommendations